Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sandoz Unveils Zero-Profit COVID-19 Portfolio

Dexamethasone On List For Low-Income Countries

Jul 16 2020

• By Kevin Grogan

Vaccine — Novartis pledges to make no profit from COVID-19 portfolio • Source: Shutterstock

Related Content

Dexamethasone COVID-19 Findings Leave Authorities Bracing for Yet Another Demand Surge

Jun 17 2020

Coronavirus Notebook: Dexamethasone Reduces Deaths In Hospitalized COVID-19 Patients

Jun 16 2020

Coronavirus Update: Novartis Joins Vaccine Efforts With Gene Therapy Approach

May 29 2020

Novartis CEO Backs Malaria Drug Against COVID-19

Mar 30 2020

Sandoz Pledges Price Stability Amid Coronavirus

Feb 27 2020

Dexamethasone Shows Potential Of Repurposed Generics Against COVID-19

Jun 18 2020

Related Companies

Novartis AG

Sandoz AG

Additional Topics

Coronavirus COVID-19 Generic Drugs Strategy Deals BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window